Global COVID-19 Prevention Trial of Hydroxychloroquine to Resume Global COVID-19 Prevention Trial of Hydroxychloroquine to Resume

A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being approved by British regulators.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Related Links:

About 200 of 1,200 clinical trials looked at anti-malaria drug hydroxychloroquine as a potential treatment for coronavirus, but fewer than 25 studies examined dexamethasone or remdesivir.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Prescriptions for chloroquine and hydroxychloroquine rose 159 percent and 86 percent, respectively, across the United States in February and March -- the early days on the COVID-19 outbreak, according to a CDC analysis.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
GENEVA, SWITZERLAND, 6 JULY 2020 – The Stop TB Partnership and Johnson &Johnson – with support from the Global Fund to Fight AIDS, TB and Malaria, and the U.S. Agency for International Development (USAID) – today announced joint efforts to help enable low- and middle-income countries to rapidly scale up use of SIRTURO® (bedaquiline) 100mg tablets in support of new, recently-released World Health Organization (WHO) treatment guidelines. Effective immediately, Johnson &Johnson will make bedaquiline available to Stop TB Partnership’s Global Drug Facility (GDF) at a price of USD$340 per six-...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: https://www.fightaging.org/newsletter/ Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out m...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Hydroxychloroquine and lopinavir/ritonavir not found to help patients in hospitalCoronavirus – latest updatesSee all our coronavirus coverageThe World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drughydroxychloroquine and combination HIV drug lopinavir/ritonavir for patients in hospital with Covid-19 after they failed to reduce mortality.The setback came as WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day. The US accounted for 53,213 of the total 212,326 new cases recorded on Friday, the WHO said.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Medical research World Health Organization World news US news Pharmaceuticals industry Science Infectious diseases Source Type: news
There is no situation so terrible that it will not be silently accepted as set in stone, only given that it has lasted for long enough to become routine. So it is with aging, and all of the pain, suffering, and death that accompanies it. The present furor surrounding COVID-19 is unusual for casting at least a little light upon the point that infectious disease largely kills older people, and in very large numbers, year in and year out. In the normal course of affairs, no-one cares until it is their turn to be old, frail, and vulnerable. The immune system decays with age, becoming simultaneously overactive (inflammag...
Source: Fight Aging! - Category: Research Authors: Tags: Medicine, Biotech, Research Source Type: blogs
Doctors of the World/Médecins du Monde is responding to COVID-19 in the sprawling refugee camps of Cox’s Bazar, southeastern Bangladesh, which are home to about one million Rohingya refugees. Our teams work with Rohingya volunteers and our local partner PULSE Bangladesh to improve healthcare in the camps and raise awareness about COVID-19 so that residents can protect themselves. Tasmin (not her real name) is a young Rohingya woman who has volunteered as a youth educator. She shared her story with us, just prior to COVID-19’s arrival in Cox’s Bazar. “We Rohingya are a minority ethnic...
Source: Doctors of the World News - Category: International Medicine & Public Health Authors: Tags: Uncategorised COVID-19 health promotion refugee camp refugees Rohingya Rohingya refugee crisis testimony Source Type: news
Authors: Udwadia ZF, Malu KN, Rana D, Joshi SR Abstract Chloroquine and Hydroxychloroquine are drugs which have been widely used in malaria and rheumatoid arthritis respectively for over 50 years. There was anecdotal evidence of their efficacy in the earlier SARS outbreak in 2003. This prompted physicians from across the world to use them in the present SARS-CoV- 2 pandemic that is currently sweeping the globe, with 5 million people already infected to date. These drugs are already in widespread use for the treatment of COVID-19 in India, mainly because they are cheap and easily available, and because of the absenc...
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
[Premium Times] Findings from the analysis of COVID Organics shows that it largely contains anti-malaria components, the Minister of Health, Osagie Ehanire, said on Thursday.
Source: AllAfrica News: Malaria - Category: Infectious Diseases Source Type: news
The bio-detection dogs are already trained to detect odours of cancers, malaria and Parkinson's disease.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
More News: COVID-19 | Health | Hydroxychloroquine | Infectious Diseases | Malaria | UK Health